Concert Pharma (CNCE) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. RXRX

Go back to Concert Pharma (CNCE) Tops Q4 EPS by 8c

Concert Pharma (CNCE) Announces Results from Part 1 of Ascending Dose Phase 1 of CTP-656; Prior PK Results Affirmed

February 29, 2016 4:08 PM EST

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) announced new results from Part 1 of its multiple ascending dose Phase 1 clinical trial in which a single-dose tablet formulation of CTP-656 was compared to the commercial tablet formulation of Kalydeco®, the current standard of care for cystic fibrosis patients with gating mutations. The results from this study confirmed CTP-656s... More